Clinic
Altamed Health Services Corp
Altamed Health Services Corp was paid $104.47M by Medicaid between Apr 2018 and Dec 2024, across 190 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 79% of everything it billed.
33Billing provider infoALTAMED HEALTH SERVICES CORP
COMMERCE, CA 90022
COMMERCE, CA 90022
33aNPI1770006728assigned 07/21/2017
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$104.47M
24GClaims1,745,388
24DCodes billed190
24AFirst – last monthApr 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in California
Rank by total paid#20 of 826
Median peer was paid$4.05M
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official YOUNG, ROBERT controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 54,794 | $9.41M | |
| 2019 | 201,927 | $14.48M | |
| 2020 | 199,257 | $13.47M | |
| 2021 | 231,917 | $14.95M | |
| 2022 | 255,294 | $12.94M | |
| 2023 | 351,395 | $17.85M | |
| 2024incomplete | 450,804 | $21.37M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 79% | 456,381 | 392,131 | $82.54M |
| 00003 | Internal/system code - not a standard HCPCS code | 19% | 86,702 | 54,529 | $19.85M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 407,203 | 272,890 | $321K |
| G9920 | Screening performed and negative | <1% | 23,827 | 15,457 | $206K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 19,855 | 15,162 | $205K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 13,097 | 9,999 | $164K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 8,894 | 6,545 | $139K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 5,544 | 4,135 | $136K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 13,127 | 10,988 | $113K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 4,243 | 1,950 | $85K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 63,427 | 43,184 | $74K |
| 0071A | <1% | 1,024 | 534 | $53K |
178 more codes
| 0072A | <1% | 792 | $42K | |
| 90686 | <1% | 19,724 | $35K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,114 | $35K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 35,469 | $29K |
| 0001A | <1% | 513 | $26K | |
| 83655 | <1% | 6,068 | $23K | |
| 0002A | <1% | 411 | $22K | |
| 90633 | <1% | 4,759 | $20K | |
| 90651 | <1% | 4,702 | $19K | |
| 90680 | <1% | 4,884 | $18K | |
| 90670 | <1% | 7,163 | $17K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 50,322 | $17K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 11,319 | $14K |
| 90698 | <1% | 3,923 | $13K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 20,551 | $13K |
| 85018 | <1% | 34,600 | $12K | |
| J3490 | Unclassified drugs | <1% | 8,808 | $11K |
| 90697 | <1% | 3,373 | $11K | |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | <1% | 1,089 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 8,343 | $10K |
| 92551 | <1% | 2,147 | $10K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 655 | $10K |
| 90716 | <1% | 1,187 | $9K | |
| 90734 | <1% | 1,382 | $9K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 40 | $9K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 69 | $8K |
| G0467 | Community health center visit, returning patient | <1% | 321 | $8K |
| 90707 | <1% | 1,095 | $8K | |
| 90837 | Psychotherapy session, about an hour | <1% | 244 | $6K |
| 90688 | <1% | 5,611 | $6K | |
| 90710 | <1% | 898 | $6K | |
| 90461 | <1% | 33,098 | $6K | |
| 90696 | <1% | 905 | $6K | |
| 90671 | <1% | 2,031 | $6K | |
| 90700 | <1% | 957 | $6K | |
| 90715 | <1% | 3,465 | $6K | |
| 0012A | <1% | 106 | $5K | |
| 90677 | <1% | 1,951 | $5K | |
| 90656 | <1% | 3,489 | $5K | |
| 90619 | <1% | 1,074 | $5K | |
| 90744 | <1% | 1,753 | $5K | |
| 0011A | <1% | 91 | $4K | |
| 90648 | <1% | 620 | $4K | |
| 0004A | <1% | 70 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 2,394 | $3K |
| 81025 | <1% | 24,335 | $3K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 161 | $3K |
| 0064A | <1% | 43 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 3,193 | $2K |
| 0031A | <1% | 39 | $2K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 53 | $2K |
| 90681 | <1% | 369 | $1K | |
| 81002 | <1% | 63,879 | $1K | |
| 90480 | <1% | 109 | $1K | |
| 99403 | <1% | 204 | $1K | |
| 99381 | <1% | 204 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,436 | $977.52 |
| 0124A | <1% | 14 | $871.00 | |
| 0154A | <1% | 13 | $871.00 | |
| 58300 | <1% | 137 | $833.00 | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 8,522 | $776.52 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 28,885 | $734.47 |
| 11981 | <1% | 17 | $626.58 | |
| 88142 | <1% | 763 | $612.00 | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 39 | $528.50 |
| 76801 | <1% | 667 | $473.05 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 15,503 | $424.66 |
| 90685 | <1% | 33 | $288.00 | |
| 99242 | <1% | 453 | $283.20 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 9,587 | $257.85 |
| 58301 | <1% | 120 | $244.38 | |
| D1120 | Dental cleaning, child | <1% | 484 | $225.00 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 16 | $199.68 |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,125 | $195.13 |
| 90381 | <1% | 31 | $153.00 | |
| 92060 | <1% | 1,350 | $135.12 | |
| D1206 | Topical application of fluoride varnish | <1% | 903 | $129.00 |
| 99451 | <1% | 93 | $125.80 | |
| 99000 | <1% | 695 | $105.07 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 353 | $93.11 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 603 | $89.59 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,221 | $85.70 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 52 | $70.05 |
| 0111A | <1% | 17 | $67.00 | |
| 92015 | Determination of refractive state | <1% | 1,657 | $47.98 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,026 | $28.44 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 353 | $23.97 |
| 82962 | <1% | 3,320 | $20.73 | |
| 99401 | <1% | 647 | $16.82 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,661 | $13.52 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 171 | $11.10 |
| 90736 | <1% | 16 | $9.00 | |
| 1126F | <1% | 13,741 | $9.00 | |
| 88720 | <1% | 284 | $8.52 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 47 | $8.21 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 296 | $0.37 |
| 0502F | 0% | 19,008 | $0.00 | |
| 3078F | 0% | 11,308 | $0.00 | |
| 3077F | 0% | 3,215 | $0.00 | |
| 1160F | 0% | 21,514 | $0.00 | |
| 97803 | 0% | 184 | $0.00 | |
| 1159F | 0% | 20,518 | $0.00 | |
| Z6400 | 0% | 12,229 | $0.00 | |
| D0220 | Intraoral - periapical first radiographic image | 0% | 1,712 | $0.00 |
| Z6300 | 0% | 13 | $0.00 | |
| D9993 | 0% | 842 | $0.00 | |
| 99173 | 0% | 1,212 | $0.00 | |
| D9430 | 0% | 55 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 378 | $0.00 |
| 59425 | 0% | 1,169 | $0.00 | |
| 90658 | 0% | 55 | $0.00 | |
| 76802 | 0% | 628 | $0.00 | |
| Z6304 | 0% | 156 | $0.00 | |
| 99442 | 0% | 61 | $0.00 | |
| 90678 | 0% | 72 | $0.00 | |
| 1158F | 0% | 210 | $0.00 | |
| 91311 | 0% | 25 | $0.00 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 27 | $0.00 |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 0% | 57 | $0.00 |
| D0274 | Bitewings - four radiographic images | 0% | 159 | $0.00 |
| Z6500 | 0% | 56 | $0.00 | |
| D0270 | 0% | 88 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 84 | $0.00 |
| D9110 | 0% | 88 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 80 | $0.00 |
| G9919 | Screening performed and positive and provision of recommendations | 0% | 16 | $0.00 |
| Z6414 | 0% | 14 | $0.00 | |
| 59025 | Fetal non-stress test | 0% | 22 | $0.00 |
| 57500 | 0% | 14 | $0.00 | |
| Z6200 | 0% | 13 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 18 | $0.00 |
| Z1034 | 0% | 3,942 | $0.00 | |
| 1125F | 0% | 9,374 | $0.00 | |
| 3079F | 0% | 3,071 | $0.00 | |
| 0501F | 0% | 765 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 2,331 | $0.00 |
| 3351F | 0% | 6,279 | $0.00 | |
| Z1032 | 0% | 604 | $0.00 | |
| 3008F | 0% | 941 | $0.00 | |
| D1330 | 0% | 3,317 | $0.00 | |
| D1310 | 0% | 1,379 | $0.00 | |
| 3074F | 0% | 10,235 | $0.00 | |
| 36416 | 0% | 645 | $0.00 | |
| D0120 | Dental checkup, returning patient | 0% | 542 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 202 | $0.00 |
| 3075F | 0% | 1,002 | $0.00 | |
| 1111F | 0% | 375 | $0.00 | |
| 96156 | 0% | 541 | $0.00 | |
| 3080F | 0% | 231 | $0.00 | |
| D1208 | Topical application of fluoride, excluding varnish | 0% | 43 | $0.00 |
| 0500F | 0% | 590 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 56 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 740 | $0.00 |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 0% | 209 | $0.00 |
| Z6410 | 0% | 285 | $0.00 | |
| Z6406 | 0% | 579 | $0.00 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 0% | 134 | $0.00 |
| D0230 | Intraoral - periapical each additional radiographic image | 0% | 743 | $0.00 |
| Z1038 | 0% | 87 | $0.00 | |
| Z6204 | 0% | 168 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 50 | $0.00 |
| 99243 | 0% | 86 | $0.00 | |
| Z6402 | 0% | 13 | $0.00 | |
| 0503F | 0% | 126 | $0.00 | |
| D0210 | Intraoral - complete series of radiographic images | 0% | 18 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 857 | $0.00 |
| 86580 | 0% | 18 | $0.00 | |
| 87807 | 0% | 124 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 265 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 65 | $0.00 |
| H2000 | Comprehensive multidisciplinary evaluation | 0% | 12 | $0.00 |
| D0603 | 0% | 51 | $0.00 | |
| D0150 | Comprehensive oral evaluation - new or established patient | 0% | 34 | $0.00 |
| 59430 | 0% | 12 | $0.00 | |
| D0602 | 0% | 43 | $0.00 | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 0% | 32 | $0.00 |
| 94760 | 0% | 15 | $0.00 | |
| 3353F | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialYOUNG, ROBERT (VP, PATIENT FINANCIAL SERVICES)
| Provider | Location | Paid |
|---|---|---|
| Altamed Health Services Corp. | Los Angeles, CA | $305.80M |
| Altamed Health Services Corp | West Covina, CA | $83.90M |
| Altamed Health Services Corp | Pico Rivera, CA | $70.97M |
| Altamed Health Services Corp | El Monte, CA | $56.32M |
| Altamed Health Services Corp | Huntington Beach, CA | $53.30M |
| Altamed Health Services Corp | Los Angeles, CA | $50.84M |
| Altamed Health Services Corp | Santa Ana, CA | $43.62M |
| Altamed Health Services Corp | Santa Ana, CA | $40.31M |
| Altamed Health Services Corp | E. Los Angeles, CA | $33.24M |
| Altamed Health Services Corp | Garden Grove, CA | $30.84M |
| Altamed Health Services Corp | Los Angeles, CA | $23.94M |
| Altamed Health Services Corp | Orange, CA | $19.54M |
| Altamed Health Services Corp | Pico Rivera, CA | $14.32M |
| Altamed Health Services Corp | Anaheim, CA | $7.95M |
| Robert L. Young, JR. , DDS | Charlotte, NC | $7.89M |
| Altamed Health Services Corp | Los Angeles, CA | $3.75M |
| Altamed Health Services Corp | Anaheim, CA | $3.62M |
| Altamed Health Services Corp | Anaheim, CA | $3.60M |
| Robert L Young 2 DDS PA | Mint Hill, NC | $2.39M |
| Altamed Health Services Corp | Los Angeles, CA | $2.03M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.